Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP1 | P03956 | 1/20 | 0.40 |
| ▸ | MMP2 | P08253 | 1/20 | 0.40 |
| ▸ | MMP3 | P08254 | 1/20 | 0.40 |
| ▸ | MMP9 | P14780 | 1/20 | 0.40 |
| ▸ | EPHX1 | P07099 | 5/20 | 0.39 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.37 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | PAOX | Q6QHF9 | 1/20 | 0.32 |
| ▸ | ADH1B | P00325 | 1/20 | 0.30 |
| ▸ | ADH1A | P07327 | 1/20 | 0.30 |
| ▸ | ADH7 | P40394 | 1/20 | 0.30 |
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13973081 | 0.91 | — | — | |
| SCHEMBL16309335 | 0.89 | EPHX1 (0.48) | MMP1MMP2EPHX1KMT2A | |
| SCHEMBL13943361 | 0.88 | MMP1 (0.37) | MMP1MMP2MMP3MMP9EPHX1 | |
| SCHEMBL17046805 | 0.87 | EPHX1 (0.58) | EPHX1ALDH1A1PAOX | |
| SCHEMBL349059 | 0.87 | MMP1 (0.33) | MMP1MMP2MMP3MMP9EPHX1 | |
| SCHEMBL4100814 | 0.85 | — | — | |
| SCHEMBL564253 | 0.85 | — | — | |
| SCHEMBL15228190 | 0.83 | — | — | |
| SCHEMBL10446327 | 0.83 | — | — | |
| SCHEMBL26760772 | 0.83 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220169815-A1 | GAS GENERATING AGENT, FOAMABLE COMPOSITION, FOAM, AND METHOD OF PRODUCING FOAM | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2022-06-02 | — | — | US | disclosed |
| US-10077336-B2 | Functionalized highly branched melamine-polyamine polymers | BASF SE (DE) | 2018-09-18 | — | — | US | disclosed |
| EP-2545123-B1 | POLYAMIDES RESISTANT TO HOT AGEING | BASF SE (DE) | 2018-05-16 | — | — | EP | disclosed |
| US-8911929-B2 | Developer and patterning process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2014-12-16 | — | — | US | disclosed |
| US-8911929-B2 | Developer and patterning process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2014-12-16 | — | — | US | disclosed |
| US-20140141377-A1 | DEVELOPER AND PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2014-05-22 | — | — | US | disclosed |
| US-20140141377-A1 | DEVELOPER AND PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2014-05-22 | — | — | US | disclosed |
| US-8466221-B2 | Polyamides that resist heat-aging | BASF SE (DE) | 2013-06-18 | — | — | US | disclosed |
| EP-2545123-A1 | POLYAMIDES RESISTANT TO HOT AGEING | BASF SE (DE) | 2013-01-16 | — | — | EP | disclosed |
| EP-2513201-A1 | FUNCTIONALIZED HIGHLY BRANCHED MELAMINE-POLYAMINE POLYMERS | BASF SE (DE) | 2012-10-24 | — | — | EP | disclosed |
| US-20050129645-A1 | Hair shaping composition comprising at least one non-hydroxide imine | L'OREAL | 2005-06-16 | — | — | US | disclosed |
| EP-1532963-A1 | Composition for straightening the hair comprising at least one imine not being an hydroxide | L'OREAL (FR) | 2005-05-25 | — | — | EP | disclosed |
| EP-1532960-A1 | Hair styling composition containing a non-hydroxide imine | L'OREAL (FR) | 2005-05-25 | — | — | EP | disclosed |
| US-6825191-B2 | ANTICOAGULANT | AJINOMOTO CO., INC. (JP) | 2004-11-30 | — | — | US | disclosed |
| US-6667356-B2 | Including an n-amidinobenzamide derivative; heat aging resistance | BRIDGESTONE CORPORATION (JP) | 2003-12-23 | — | — | US | disclosed |
| US-20030186969-A1 | Benzodiazepine derivatives | AJINOMOTO CO. INC (JP) | 2003-10-02 | — | — | US | disclosed |
| EP-1329450-A1 | BENZODIAZEPINE DERIVATIVE | Ajinomoto Co., Inc. (JP) | 2003-07-23 | — | — | EP | disclosed |
| US-20030134947-A1 | Containing imine, amidine or guanidine antioxidants to improve heat aging resistance; may be substituted by acyl, thioacyl or additional imine groups | BRIDGESTONE CORPORATION, OTSUKA CHEMICAL CO., LTD. | 2003-07-17 | — | — | US | disclosed |
| US-6515055-B1 | Excellent in heat aging resistance due to addition of compounds exemplified by N'-(N-benzoylamidino) benzoic acid hydrazide | BRIDGESTONE CORPORATION (JP) | 2003-02-04 | — | — | US | disclosed |
| EP-1101793-A1 | Heat ageing resistant rubber composition | Bridgestone Corporation (JP) | 2001-05-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030186969-A1 | Benzodiazepine derivatives | GABRA1, F11, GABRA4 | MMP1 2960/4885MMP2 1686/4885MMP3 1419/4885 |
| US-20050129645-A1 | Hair shaping composition comprising at least one non-hydroxide imine | KRT18, INHA, H1-5 | MMP1 158/4885MMP2 1269/4885MMP3 2395/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.